Apollon Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Buy
+8,226
New +$265K ﹤0.01% 1211
2024
Q1
Sell
-26,439
Closed -$276K 1162
2023
Q4
$276K Buy
26,439
+60
+0.2% +$560 0.01% 871
2023
Q3
$269K Sell
26,379
-3,649
-12% -$34K 0.01% 737
2023
Q2
$226K Sell
30,028
-285
-0.9% -$2.31K 0.01% 823
2023
Q1
$268K Buy
30,313
+6,685
+28% +$66.1K 0.02% 712
2022
Q4
$215K Sell
23,628
-235
-1% -$2.05K 0.02% 763
2022
Q3
$193K Sell
23,863
-200
-0.8% -$1.77K 0.02% 726
2022
Q2
$181K Buy
24,063
+4,125
+21% +$35.9K 0.02% 690
2022
Q1
$187K Sell
19,938
-1,600
-7% -$13.4K 0.01% 701
2021
Q4
$173K Buy
+21,538
New +$194K 0.01% 722

Other funds holding TEVA